U.S. researchers develop method to identify future SARS-CoV-2 mutations affecting rapid antigen test

LOS ANGELES, Sept. 15 (Xinhua) -- U.S. researchers have developed a method to evaluate how mutations to SARS-CoV-2 can affect recognition by antibodies used in rapid antigen tests, according to a release of the U.S. National Institutes of Health (NIH) on Thursday.

As new variants of the SARS-CoV-2 virus continue to emerge, concerns have been raised about the performance of rapid antigen tests.